Sunrise Secures €6.5 Million In Funding To Deploy Its Sleep Apnea Diagnostic Solution Internationally

12/15/21, 12:00 PM

Location

namur

Money raised

€6.5 million

Sunrise, a healthtech company founded in 2015 in Belgium, has just closed a €3.25 million fundraising round. Led by Kurma Partners, this round of financing, in which the Vives-IUF fund linked to UCLouvain and Namur Invest also participated, has the objective of launching and internationally marketing the company's first diagnostic product for sleep apnea. In addition to this €3.25 million round of funding, there is also €3.25 million in non-dilutive funding from the European Innovation Council, launched in 2021 by the European Commission to transform scientific ideas into promising innovations, and the Walloon Region.

Company Info

Company

Sunrise

Location

namur, namur, belgium

Additional Info

Founded in 2015 by Laurent and Pierre Martinot, Sunrise aims to democratize access to care for sleep apnea syndrome. This serious respiratory disorder is known for multiplying mortality risk by factor 3. The Sunrise innovation is based on more than ten years of research : the technology detects respiratory events based on the analysis of the respiratory drive (which is reflected in the contractions of the respiratory muscles and the movements these cause at the level of the chin). In 2021, it gained an award at the CES in Las Vegas. Currently, about twenty people (located in Belgium and France) work for Sunrise, a scale-up that aims to market its medical device in the United States and France. www.hellosunrise.com [1] Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MS, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7:687-698. – https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-2600(19)30198-5.pdf [2] Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study – https://pubmed.ncbi.nlm.nih.gov/25682233/ [3] Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MS, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7:687-698. https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-2600(19)30198-5.pdf [4] Frost & Sullivan, Hidden Health Crisis Costing America Billions (2016) – page 4: https://aasm.org/resources/pdf/sleep-apnea-economic-crisis.pdf SOURCE Sunrise